• info@betterlife-technologies.com
  • + 202 22576731
  • 09:00 – 17:00 Saturday to Thursday

New Valve Technology

New Valve Technology

NVT is dedicated to developing and marketing innovative technologies for the minimally invasive treatment of all heart valves. Together with physicians and medical institutions, we pioneer safe and cost-effective therapies. Our vision is to make treating valvular heart disease as easy and safe as possible. And to restore patients’ quality of life. Headquarter of the company founded in 2007 is Morges, Switzerland. In Hechingen, Germany the products are developed and produced – Made in Germany.

Products

The ALLEGRA™ TAVI System TF has been designed for uncompromised hemodynamic performance with single digit mean pressure gradients and high effective orifice areas1-3. The ALLEGRA™ TAVI System TF is a catheter-based transfemoral heart valve system. It is indicated for the treatment of severe calcified aortic valve stenosis in high risk patients with elevated surgical risk or in patients with a symptomatic degeneration of an aortic valve bioprosthesis.

ALLEGRA

The ALLEGRA™ TAVI System TF is a catheter-based transfemoral heart valve system. It is indicated for the treatment of severe calcified aortic valve stenosis in high risk patients with elevated surgical risk or in patients with a symptomatic degeneration of an aortic valve bioprosthesis.

The outstanding hemodynamics of the ALLEGRA™ are particularly important in small native annuli and surgical valves (ViV). With its supra-annular design, excellent hemodynamics and radiopaque gold markers, ALLEGRA™ is also an excellent choice for implantation into a degenerative surgical biological aortic valve. Its dependable release mechanism facilitates straightforward, safe and effective implantation while maintaining biological circulation.